
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
The test could help doctors to identify women at high risk of the disease allowing them to take preventive medicines and switch to healthier lifestyles.
The test could help doctors to identify women at high risk of the disease allowing them to take preventive medicines and switch to healthier lifestyles.
Researchers have identified a 'genetic switch', carried by one in five women, that doubles their risk of developing breast cancer.
Read the full story:
Source: The Telegraph






